DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Boston Convention and Exhibition Center

2013年6月23日 (日) 午前 8:30 - 2013年6月27日 (木) 午後 12:45

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Partnering and Outsourcing Challenges in India: The New Paradigm Shifts

Session Chair(s)

Anupama  Ramkumar, MD

Anupama Ramkumar, MD

Consultant, Clinical Development

Dr. Reddy's Laboratories Ltd., India

Insourcing to India: The Real Politics of Building a Dynamic partnership between US and Hyderabad Regulatory Professionals

Learning Objective : Identify the unique challenges related to the outsourcing of clinical trials of biologics/biosimilars; Analyze the differentiators and the medical and project management issues related to these trials; Describe current partnering trends and the paradigm shift from mono-centric to poly-centric, frugal innovation models; Explain how to go beyond basic cultural and management issues and use more advanced strategies for integrating diverse skills around operational deliverables.

Speaker(s)

Anupama  Ramkumar, MD

Clinical Trials in Biosimilars or Follow-on Biologics: Outsourcing Strategies and Challenges

Anupama Ramkumar, MD

Dr. Reddy's Laboratories Ltd., India

Consultant, Clinical Development

Nidhi  Saxena, MBA

Global Licensing and Co-development Models: Innovative Route to Faster Commercialization

Nidhi Saxena, MBA

Karmic Lifesciences, Inc., India

Founder and CEO

Raffy H. Chilingerian, PHD, MS

Insourcing to India: The Real Politics of Building a Dynamic partnership between US and Hyderabad Regulatory Professionals

Raffy H. Chilingerian, PHD, MS

Novartis Pharmaceuticals Corporation, United States

Senior Regulatory Operations Manager

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。